Differentiation of radiation necrosis from tumor progression using proton magnetic resonance spectroscopy

We report on a young woman who was treated by stereotactic radiotherapy for recurrence of an initially resected low-grade astrocytoma. MRI follow-up examination 7 months after radiotherapy showed a gadolinium-DTPA-enhancing mass lesion indicative of high-grade tumor progression. This assumption was...

Full description

Saved in:
Bibliographic Details
Published inNeuroradiology Vol. 44; no. 3; pp. 216 - 222
Main Authors SCHLEMMER, H.-P, BACHERT, P, HENZE, M, BUSLEI, R, HERFARTH, K. K, DEBUS, J, VAN KAICK, G
Format Journal Article
LanguageEnglish
Published Berlin Springer 01.03.2002
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:We report on a young woman who was treated by stereotactic radiotherapy for recurrence of an initially resected low-grade astrocytoma. MRI follow-up examination 7 months after radiotherapy showed a gadolinium-DTPA-enhancing mass lesion indicative of high-grade tumor progression. This assumption was also supported by positron emission tomography with [2-18F]fluoro-2-deoxy-D-glucose (FDG-PET). In contrast, proton MR spectroscopy (1H-MRS) indicated radiation necrosis, which was confirmed histopathologically in surgical specimens. Subsequent follow-up examinations up to 19 months after surgery showed no evidence of tumor recurrence.
ISSN:0028-3940
1432-1920
DOI:10.1007/s002340100703